0001127602-16-049605.txt : 20160420 0001127602-16-049605.hdr.sgml : 20160420 20160420171925 ACCESSION NUMBER: 0001127602-16-049605 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160420 FILED AS OF DATE: 20160420 DATE AS OF CHANGE: 20160420 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANDINE MICHAEL J CENTRAL INDEX KEY: 0001235600 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 161582010 MAIL ADDRESS: STREET 1: 88 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 021394136 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2016-04-20 0001520262 Alkermes plc. ALKS 0001235600 LANDINE MICHAEL J 852 WINTER ST. WALTHAM MA 02451 1 SVP, Corp Dev., Alkermes, Inc. Ordinary Shares 2016-04-20 4 M 0 12657 20.79 A 159419 D Ordinary Shares 2016-04-20 4 M 0 4218 20.79 A 163637 D Ordinary Shares 2016-04-20 4 S 0 9993 40.971 D 153644 D Ordinary Shares 2016-04-20 4 S 0 6882 41.2641 D 146762 D Non Qualified Stock Option (Right to Buy) 20.79 2016-04-20 4 M 0 12657 0 D 2016-05-02 Ordinary Shares 12657 0 D Incentive Stock Option (Right to Buy) 20.79 2016-04-20 4 M 0 4218 0 D 2016-05-02 Ordinary Shares 4218 0 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.235 to $41.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.23 to $41.33. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. These options are fully vested in accordance with their terms. /s/ Jennifer Baptiste, attorney-in-fact for Michael J. Landine 2016-04-20